Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2018

Jun 11, 2018

29841_dirs_2018-06-11_222d4bb7-3023-48a7-b7e9-1feb78899560.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2018-06-08

Reporting Person: Kuntz Richard (SVP & Chief Medical & Science)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-06-08 Ordinary Shares S 11500 $87.13 Disposed 105923 Direct

Footnotes

F1: The price is a weighted average price. These shares were sold in multiple transactions in prices ranging from $87.09 to $87.155, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote in this Form 4.

F2: This balance increased by 316 shares due to exempt transactions such as dividend reinvestment.